作者:Jody Morgan、Rachada Haritakul、Paul A. Keller
DOI:10.1016/s0960-894x(03)00241-5
日期:2003.5
A selection of novel anilinopyrimidine analogues have been found to have micromolar activity against Mycobacterium tuberculosis. This could potentially generate new lead compounds in the fight against multi-drug resistant tuberculosis.
已经发现了一些新的苯胺基嘧啶类似物对结核分枝杆菌具有微摩尔活性。在与耐多药结核病作斗争中,这可能会产生新的先导化合物。